New Products

October 2003
Urologic Nursing;Oct2003, Vol. 23 Issue 5, p384
Academic Journal
Product Review
Reports developments related to medicine. Increase of the presence of Yamanouchi Pharmaceutical Co. Ltd. in pharmaceutical market; Result of the complexed prostate specific antigen test released by Bayer Diagnostics; Effectiveness of dietary supplement Prelief in improving quality of life for patients suffering with overactive bladder.


Related Articles

  • Former Bayer plant ready for tech tenants to set up shop. Soder, Chuck // Crain's Cleveland Business;1/14/2008, Vol. 29 Issue 2, p3 

    The article reports that the owner of the Oberlin, Ohio-based plant of the pharmaceutical company Bayer Diagnostics, Kevin Flanigan, has started recruiting young technology companies and other businesses to fill the half-empty plant. Moreover, Flanigan states that he will remove Bayer's sign at...

  • Solifenacin Succinate (VESIcare): Overactive Bladder Therapy. Kosier, June Hannay; Combest, Wendell; Newton, Marian // Urologic Nursing;Dec2006, Vol. 26 Issue 6, p496 

    The article discusses the potential of Solifenacin succinate, a U.S. Food and Drug Administration-approved drug for the treatment of overactive bladder (OAB). Produced by Yamanouchi Pharmaceutical Co. with marketing partner GlaxoSmithKline, the drug relieves the symptoms of OAB by relaxing the...

  • Pharmaceutical and chemical giant finds 'a third way'.  // Personnel Today;11/12/2002, p29 

    Focuses on an approach developed by a chemical and pharmaceutical group Bayer Diagnostics to meet the future needs of its business. Basis of the approach; Survey conducted by Bayer Diagnostics to determine its employee's attitude; Feedback program conducted by managers and supervisors.

  • Headache help.  // Pharmaceutical Executive;Jul98, Vol. 18 Issue 7, p98 

    Reports on the agreement signed by Glaxo Wellcome and Yamanouchi Shaklee Pharma (YSP) for the development and commercialization of prescription products for migraine treatment using YSP's Wowtab technology.

  • Analyze This. Hoffman, Mala // Westchester County Business Journal;1/13/2003, Vol. 42 Issue 2, pT1 

    Focuses on the launch of Complexed PSA (cPSA) test for the fight against prostate cancer by Bayer Diagnostics in Tarrytown, New York. Innovation in medical technology and pharmaceutical development; Creation of sophisticated diagnostic devices; Approval of the cPSA test by the Food and Drug...

  • Products, innovations and productivity. Dunham, Dottie // MLO: Medical Laboratory Observer;Nov2003, Vol. 35 Issue 11, p22 

    Interviews Bayer Diagnostics president and physician Wolfgang Hartwig concerning the challenges of the company. Health care products provided by the firm; Testing, information and services of Bayer Diagnostics in response to bioterrorism; Effect of the shortage of clinical laboratory...

  • Mildison.  // Royal Society of Medicine: Medicines;2002, p365 

    This article presents information on proprietary, prescription-only drug Mildison from Yamanouchi. It can be used to treat mild inflammatory skin conditions, such as eczema and is available as a cream. It is a preparation of the corticosteroid and anti-inflammatory hydrocortisone.

  • Yamanouchi Shaklee Pharma.  // Pharmaceutical Executive;Dec97 Special Issue, Vol. 17, p102 

    Profiles Palo Alto, California-based Yamanouchi Shaklee Pharma. Corporate description; Markets served; Services; Technologies; Facilities.

  • COMPANY SPOTLIGHT -- Astellas Pharma.  // PharmaWatch: CNS;Dec2009, Vol. 8 Issue 12, p17 

    The article profiles Astellas Pharma Inc., the largest pharmaceutical company in Japan which ranks 15th in the global market. It states that the company was created through the merger of Yamanouchi Pharmaceutical Co. Ltd. and Fujisawa Pharmaceutical Co. Ltd. in 2005. It notes that Astellas...


Read the Article


Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics